Public Health | November 10, 2021
Takeda receives the Arogaya CIBioD Leadership Award
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The Lucent 3D Lumbar Interbody System features a functionally unique multi-component device manufactured in a 3D printing sequence
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Subscribe To Our Newsletter & Stay Updated
